Nicolas Malaquin

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Prostate Cancer

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sophie Gilbert, Benjamin Péant, Nicolas Malaquin, Véronique Tu, Hubert Fleury, Kim Leclerc-Desaulniers, Francis Rodier, Anne-Marie Mes-Masson, Fred Saad
Targeting IKKε in Androgen-Independent Prostate Cancer Causes Phenotypic Senescence and Genomic Instability. Molecular cancer therapeutics 21 (3) (2022)
Julie Lafontaine, Guillaume B Cardin, Nicolas Malaquin, Jean-Sébastien Boisvert, Francis Rodier, Philip Wong
Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells. Cancers 13 (3) (2021)
Nicolas Malaquin, Arthur Vancayseele, Sophie Gilbert, Laureen Antenor-Habazac, Marc-Alexandre Olivier, Zakia Ait Ali Brahem, Fred Saad, Guila Delouya, Francis Rodier
DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity. Cells 9 (7) (2020)
Nicolas Malaquin, Marc-Alexandre Olivier, Aurélie Martinez, Stéphanie Nadeau, Christina Sawchyn, Jean-Philippe Coppé, Guillaume Cardin, Frédérick A Mallette, Judith Campisi, Francis Rodier
Non-canonical ATM/MRN activities temporally define the senescence secretory program. EMBO reports 21 (10) (2020)